Gene · 5885
Papers3,897
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,897
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RAD21 regulation of the enhancer-promoter chromatin loop of RAD51 promotes PARPi resistance in ovarian cancer. | J Transl Med | 2026 | 42251422 | PubTator, text mining | PubMed |
| 3D chromatin architecture-related genes orchestrate LUAD evolution and therapy resistance: insights from integrative machine learning and spatial single-cell mapping. | Funct Integr Genomics | 2026 | 42240917 | PubTator, text mining | PubMed |
| Cohesin collisions maintain ordered nucleosome architecture at boundaries and promoters. | bioRxiv | 2026 | 42239201 | PubTator, text mining | PubMed |
| ER-Golgi dysfunction and vesicular transport alterations in rheumatoid arthritis immune cells. | Front Immunol | 2026 | 42220485 | PubTator, text mining | PubMed |
| A Multi-Omics Framework Reveals Tumor Heterogeneity and Predicts Therapeutic Targets in Renal Cell Carcinoma. | Int J Mol Sci | 2026 | 42196432 | PubTator, text mining | PubMed |
| RFX5 as a regulator of spatial chromatin contacts and gene expression. | Commun Biol | 2026 | 42177279 | PubTator, text mining | PubMed |
| RAD21 drives tumor progression and confers anti-PD-1 resistance by reprogramming tumor-associated macrophages via upregulation of CSF1 signaling. | Cancer Lett | 2026 | 42140344 | PubTator, text mining | PubMed |
| Development and Characterization of a Novel Congenital Acute Erythroid Leukemia Cell Line with Unique Features. | Cancers (Basel) | 2026 | 42122191 | PubTator, text mining | PubMed |
| Pds5 regulates sister chromatid cohesion by controlling cohesin ATPase activity through the Eco1-Smc3 acetylation pathway. | Nucleic Acids Res | 2026 | 42120045 | PubTator, text mining | PubMed |
| Efficacy of olaparib in advanced cancers with somatic or germline mutations in BAP1, BARD1, BRIP1 and PALB2. | ESMO Open | 2026 | 42105598 | PubTator, text mining | PubMed |
| The biogenesis of extrachromosomal circular DNA is associated with enhancer-promoter dynamics and chromatin architecture. | Int J Biol Macromol | 2026 | 42067092 | PubTator, text mining | PubMed |
| Outcomes of hemophagocytic lymphohistiocytosis in acute myeloid leukemia: the 3-site Mayo Clinic experience. | Blood Neoplasia | 2026 | 42058285 | PubTator, text mining | PubMed |
| Impact of Copy Number Alterations on Human Papillomavirus (HPV)-Induced and HPV-Independent Penile Cancers. | Lab Invest | 2026 | 42031074 | PubTator, text mining | PubMed |
| Impact of Genetic Mutations on Response and Time to Progression after Radioembolization of Breast Cancer Liver Metastases. | J Vasc Interv Radiol | 2026 | 42025916 | PubTator, text mining | PubMed |
| SMC complex unidirectionally translocates DNA by coupling segment capture with an asymmetric kleisin path. | Elife | 2026 | 42017784 | PubTator, text mining | PubMed |
| Dissecting Pirtobrutinib Resistance in Mantle Cell Lymphoma Through Single-Cell Multi-Omics. | Am J Hematol | 2026 | 41998849 | PubTator, text mining | PubMed |
| TAD boundaries and gene activity are uncoupled. | Elife | 2026 | 41983545 | PubTator, text mining | PubMed |
| The Molecular Signature of Early-Onset Colorectal Cancer Liver Metastases: Distinct Biology and Clinical Challenges. | Int J Mol Sci | 2026 | 41977468 | PubTator, text mining | PubMed |
| Genomic determinants of response to alpelisib plus fulvestrant in the SOLAR-1 trial. | Ann Oncol | 2026 | 41967638 | PubTator, text mining | PubMed |
| ASO therapy rescues NOTCH2NLC GGC repeat expansion-induced genomic damage, 3D chromatin structural abnormalities, and senescence. | Nat Commun | 2026 | 41942455 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5885/papers?page=2